Cell-free mitochondrial DNA may predict the risk of post-operative complications and outcomes in surgical aortic valve replacement patients

Abstract excerpt

Surgical aortic valve replacement (AVR) is the standard of care for severe aortic valve disease; however, post-operative complications continue to pose challenges. Inflammation caused by increased release of cell-free mitochondrial DNA (cf-mtDNA) during surgery may be a contributing factor. The aim of this pilot study was to investigate the relationship between cf-mtDNA release and the risk of...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Aortic Disease and Treatment Approaches
• Share to Cardiac Valve Diseases and Treatments
• Share to Infective Endocarditis Diagnosis and Management